Protein Biomarkers for COPD Outcomes is a research paper published in CHEST Journal (2021). On theSindex it has a DataRank of 0.681. It has been cited 93 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.681
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →National Heart, Lung, and Blood Institute
Grant: 1R01HL137995
National Heart, Lung, and Blood Institute
Grant: 1R01HL152735-01
Multi-omic networks associated with COPD progression in TOPMed Cohorts
NHLBI NIH HHS
Grant: R01 HL152735
NHLBI NIH HHS
Grant: R01 HL137995
NHLBI NIH HHS
Grant: K08 HL141770
National Institutes of Health
Grant: 1R01HL137995-01A1
Biomarker of Lung Disease in African Americans
National Institutes of Health
FWCI
10.04
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals
Additional file 6 of Proteomics and metabolomics profiling reveal panels of circulating diagnostic biomarkers and molecular subtypes in stable COPD
Additional file 6 of Proteomics and metabolomics profiling reveal panels of circulating diagnostic biomarkers and molecular subtypes in stable COPD
Additional file 7 of Proteomics and metabolomics profiling reveal panels of circulating diagnostic biomarkers and molecular subtypes in stable COPD
Additional file 7 of Proteomics and metabolomics profiling reveal panels of circulating diagnostic biomarkers and molecular subtypes in stable COPD
Additional file 8 of Proteomics and metabolomics profiling reveal panels of circulating diagnostic biomarkers and molecular subtypes in stable COPD
Additional file 8 of Proteomics and metabolomics profiling reveal panels of circulating diagnostic biomarkers and molecular subtypes in stable COPD
Additional file 9 of Proteomics and metabolomics profiling reveal panels of circulating diagnostic biomarkers and molecular subtypes in stable COPD
Additional file 9 of Proteomics and metabolomics profiling reveal panels of circulating diagnostic biomarkers and molecular subtypes in stable COPD
Additional file 2 of Proteomic associations with forced expiratory volume: a Mendelian randomisation study
Additional file 2 of Proteomic associations with forced expiratory volume: a Mendelian randomisation study
Additional file 3 of Proteomic associations with forced expiratory volume: a Mendelian randomisation study
Additional file 3 of Proteomic associations with forced expiratory volume: a Mendelian randomisation study
Additional file 4 of Proteomic associations with forced expiratory volume: a Mendelian randomisation study
Additional file 4 of Proteomic associations with forced expiratory volume: a Mendelian randomisation study
Additional file 6 of Proteomic associations with forced expiratory volume: a Mendelian randomisation study
Additional file 6 of Proteomic associations with forced expiratory volume: a Mendelian randomisation study
Additional file 5 of Proteomic associations with forced expiratory volume: a Mendelian randomisation study
Additional file 5 of Proteomic associations with forced expiratory volume: a Mendelian randomisation study
Additional file 1 of Proteomic associations with forced expiratory volume: a Mendelian randomisation study
Additional file 1 of Proteomic associations with forced expiratory volume: a Mendelian randomisation study